Current Neuro-Oncology
Volume
22 Number 7
15 April 2020
Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 7, 15 April
Sarkar
S, Yang R, Mirzaei R, Rawji K, Poon C, Mishra MK, Zemp FJ, Bose P,
Kelly J, Dunn JF, Yong VW.
Control
of brain tumor growth by reactivating myeloid cells with
niacin.
Sci
Transl Med.
2020
Apr 1, 2020;12(537):eaay9924∟.
doi: 10.1126/scitranslmed.aay9924∟.
PMID: 32238578∟.
Laboratory
investigation. ˍ
Ullrich
NJ, Prabhu SP, Reddy AT, Fisher MJ, Packer R, Goldman S, Robison
NJ, Gutmann DH, Viskochil DH, Allen JC, Korf B, Cantor A, Cutter
G, Thomas C, Perentesis JP, Mizuno T, Vinks AA, Manley PE, Chi SN,
Kieran MW; NF Clinical Trials Consortium.
A
Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for
Recurrent, Radiographic-Progressive Neurofibromatosis Type
1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis
Clinical Trials Consortium Study.
Neuro
Oncol.
2020
Apr 1, 2020;22(10):1527-1535∟.
doi: 10.1093/neuonc/noaa071∟.
PMID: 32236425∟.
Interventional
study. ˍ
Bulubas
L, Sardesh N, Traut T, Findlay A, Mizuiri D, Honma SM, Krieg SM,
Berger MS, Nagarajan SS, Tarapore PE.
Motor
Cortical Network Plasticity in Patients With Recurrent Brain
Tumors.
Front
Hum Neurosci.
2020 Apr 3, 2020;14:118∟.
doi: 10.3389/fnhum.2020.00118∟.
PMID: 32317952∟.
Laboratory
investigation. ˍ
Fisher
BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers
CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA,
Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y,
Wahl DR, Strasser JF, Won M, Mehta MP.
Phase
II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for
High Risk Low-Grade Gliomas: Long-term Results of Radiation
Therapy Oncology Group (RTOG) 0424.
Int
J Radiat Oncol Biol Phys.
2020 Apr 3, 2020;107(4):720-725∟.
doi: 10.1016/j.ijrobp.2020.03.027∟.
PMID: 32251755∟.
Interventional
study. ˍ
Yaprak
G, Isık N, Gemici C, Pekyurek M, Ceylaner Bıcakcı
B, Demircioglu F, Tatarlı N.
Stereotactic
Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment
Option.
Stereotact
Funct Neurosurg.
2020
Apr 3, 2020;98(3):167-175∟.
doi: 10.1159/000505706∟.
PMID: 32248188∟.
Observational
study. ˍ
Carles
C, Esquirol Y, Turuban M, Piel C, Migault L, Pouchieu C, Bouvier
G, Fabbro-Peray P, Lebailly P, Baldi I.
Residential
proximity to power lines and risk of brain tumor in the general
population.
Environ
Res.
2020 Apr 4, 2020;185:109473∟.
doi: 10.1016/j.envres.2020.109473∟.
PMID: 32278161∟.
Observational
study. ˍ
Schröter
N, Lützen N, Doostkam S, Berger B.
Glioblastoma
evolving within 10 days following unremarkable computer tomography
of the brain: a case report.
Int
J Neurosci. 2020 Apr 7, 2021;131(7):711-714∟
.
doi: 10.1080/00207454.2020.1753730∟.
PMID: 32253959∟.
Case
report. ˍ
Andrews
C, Prayson RA.
1p/19q
co-deleted fibrillary astrocytomas: Not everything that is
co-deleted is an oligodendroglioma.
Ann
Diagn Pathol. 2020 Apr 8;46:151519∟.
doi: 10.1016/j.anndiagpath.2020.151519∟.
PMID: 32305004∟.
Observational
study.
ˍ
Guerrini-Rousseau
L, Abbas R, Huybrechts S, Kieffer-Renaux V, Puget S, Andreiuolo F,
Beccaria K, Blauwblomme T, Bolle S, Dhermain F, Longaud A, Roujeau
T, Sainte-Rose C, Tauziede-Esperiat A, Varlet P, Zerah M,
Valteau-Couanet D, Dufour C, Grill J.
Role
of neoadjuvant chemotherapy in metastatic medulloblastoma: a
comparative study in 92 children.
Neuro
Oncol. 2020 Apr 8;22(11):1686-1695∟.
doi: 10.1093/neuonc/noaa083∟.
PMID: 32267940∟.
Observational
study.
ˍ
Ahmadipour
Y, Gembruch O, Pierscianek D, Sure U, Jabbarli R.
Does
the expression of glial fibrillary acid protein (GFAP) stain in
glioblastoma tissue have a prognostic impact on
survival?
Neurochirurgie.
2020 Apr 9, 2020;66(3):150-154∟.
doi: 10.1016/j.neuchi.2019.12.012∟.
PMID: 32278699∟.
Observational
study. ˍ
Chen
X, Zhang B, Pan S, Sun Q, Bian L.
Chordoid
Glioma of the Third Ventricle: A Case Report and a Treatment
Strategy to This Rare Tumor.
Front
Oncol. 2020 Apr 9;10:502∟.
doi: 10.3389/fonc.2020.00502∟.
PMID: 32328466∟.
Case
report.
ˍ
Das
D, Mahanta LB, Ahmed S, Baishya BK.
Classification
of childhood medulloblastoma into WHO-defined multiple subtypes
based on textural analysis.
J
Microsc.
2020
Apr 9, 2020;279(1):26-38∟.
doi: 10.1111/jmi.12893∟.
PMID: 32271463∟.
Laboratory
investigation. ˍ
Guidi
M, Giunti L, Buccoliero AM, Santi M, Spacca B, De Masi S, Genitori
L, Sardi I.
Use
of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged
Less Than 12 Months Treated for Aggressive Brain Tumors.
Front
Pediatr.
2020 Apr 9, 2020;8:135∟.
doi: 10.3389/fped.2020.00135∟.
PMID: 32328470∟.
Observational
study. ˍ
Liu
Z, Feng S, Li J, Cao H, Huang J, Fan F, Cheng L, Liu Z, Cheng Q.
The
Epidemiological Characteristics and Prognostic Factors of
Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and
Adult Patients.
Front
Oncol.
2020
Apr 9, 2020;10:391∟.
doi: 10.3389/fonc.2020.00391∟.
PMID: 32328455∟.
Observational
study. ˍ
Kinori
M, Armarnik S, Listernick R, Charrow J, Zeid JL.
Neurofibromatosis
type 1 associated optic pathway glioma in children - a follow up
of 10 years or more.
Am
J Ophthalmol. 2020 Apr 10, 2021;221:91-96∟.
doi: 10.1016/j.ajo.2020.03.053∟.
PMID: 32283094∟.
Observational
study. ˍ
*
Komakech
A, Im JH, Gwak HS, Lee KY, Kim JH, Yoo BC, Cheong H, Park JB, Kwon
JW, Shin SH, Yoo H.
Dexamethasone
Interferes with Autophagy and Affects Cell Survival in Irradiated
Malignant Glioma Cells.
J
Korean Neurosurg Soc. 2020 Apr 10, 2020;63(5):566-578∟.
doi: 10.3340/jkns.2019.0187∟.
PMID: 32272509∟.
Laboratory
investigation. ˍ
Almahariq
F, Raguz M, Romic D, Dlaka D, Oreskovic D, Sesar P, Chudy D.
A
biphasic tumor in posterior cranial fossa and the pineal region in
young adult.
Surg
Neurol Int. 2020 Apr 11, 2020;11:64∟.
doi: 10.25259/SNI_288_2019∟.
PMID: 32363059∟.
Case
report. ˍ
Haque
W, Verma V, Brian Butler E, Teh BS.
Prognostic
role of chemotherapy, radiotherapy dose, and extent of surgical
resection in adult medulloblastoma.
J
Clin Neurosci.
2020
Apr 11, 2020;76:154-160∟.
doi: 10.1016/j.jocn.2020.04.002∟.
PMID: 32291240∟.
Observational study. ˍ
Papale
M, Buccarelli M, Mollinari C, Russo MA, Pallini R, Ricci-Vitiani
L, Tafani M.
Hypoxia,
Inflammation and Necrosis as Determinants of Glioblastoma Cancer
Stem Cells Progression.
Int
J Mol Sci.
2020
Apr 11, 2020;21(8):E2660∟.
doi: 10.3390/ijms21082660∟.
PMID:
32290386∟.
Laboratory
investigation. ˍ
Shimizu
T, Matsushima S, Fukasawa N, Akasaki Y, Mori R, Ojiri
H.
Differentiating
between glioblastomas with and without isocitrate dehydrogenase
gene mutation by findings on conventional magnetic resonance
images.
J
Clin Neurosci.
2020
Apr 11, 2020 Jun;76:140-144∟.
doi: 10.1016/j.jocn.2020.04.016∟.
PMID: 32291242∟.
Observational study. ˍ
Chen
J, Lin Z, Barrett L, Dai L, Qin Z.
Identification
of new therapeutic targets and natural compounds against diffuse
intrinsic pontine glioma (DIPG).
Bioorg
Chem.
2020
Apr 13, 2020;99:103847∟.
doi: 10.1016/j.bioorg.2020.103847∟.
PMID: 32311581∟.
Laboratory investigation. ˍ
Fangusaro
J, Bandopadhayay P.
The
"Risk" in Pediatric Low-Grade Glioma.
Cancer
Cell. 2020 Apr 13, 2020;37(4):424‐425∟.
doi: 10.1016/j.ccell.2020.03.020∟.
PMID: 32289265∟.
Comment.
ˍ
Refers
to:
Ryall
S, et al.,Integrated Molecular and Clinical Analysis of 1,000
Pediatric Low-Grade Gliomas.
Cancer Cell. 2020 Apr 13,
2020;37(4):569‐583.e5∟.
doi: 10.1016/j.ccell.2020.03.011∟.
PMID: 32289278∟.
Laboratory investigation. ˍ
Ryall
S, Zapotocky M, Fukuoka K, Nobre L, Guerreiro Stucklin A, Bennett
J, Siddaway R, Li C, Pajovic S, Arnoldo A, Kowalski PE, Johnson M,
Sheth J, Lassaletta A, Tatevossian RG, Orisme W, Qaddoumi I,
Surrey LF, Li MM, Waanders AJ, Gilheeney S, Rosenblum M, Bale T,
Tsang DS, Laperriere N, Kulkarni A, Ibrahim GM, Drake J, Dirks P,
Taylor MD, Rutka JT, Laughlin S, Shroff M, Shago M, Hazrati LN,
D'Arcy C, Ramaswamy V, Bartels U, Huang A, Bouffet E, Karajannis
MA, Santi M, Ellison DW, Tabori U, Hawkins C.
Integrated
Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade
Gliomas.
Cancer
Cell. 2020 Apr 13;37(4):569‐583.e5∟.
doi: 10.1016/j.ccell.2020.03.011∟.
PMID: 32289278∟.
Laboratory investigation, Observational study.
ˍ
Shao
J, Radakovich NR, Grabowski M, Borghei-Razavi H, Knusel K, Joshi
KC, Muhsen BA, Hwang L, Barnett GH, Mohammadi AM.
Lessons
Learned in Using Laser Interstitial Thermal Therapy for Treatment
of Brain Tumors: A Case Series of 238 Patients from a Single
Institution.
World
Neurosurg. 2020 Apr 13, 2020 Jul;139:e345-e354∟.
doi: 10.1016/j.wneu.2020.03.213∟.
PMID: 32298824∟.
Observational study. ˍ
Su
JM, Murray JC, McNall-Knapp RY, Bowers DC, Shah S, Adesina AM,
Paulino AC, Jo E, Mo Q, Baxter PA, Blaney SM.
A
phase 2 study of valproic acid and radiation, followed by
maintenance valproic acid and bevacizumab in children with newly
diagnosed diffuse intrinsic pontine glioma or high-grade
glioma.
Pediatr
Blood Cancer. 2020 Apr 14, 2020;67(6):e28283∟.
doi: 10.1002/pbc.28283∟.
PMID: 32285998∟.
Interventional
study. ˍ
Wallace
D, Taylor DR, Pan H, Hwang S, Lucas JT Jr, Klimo P Jr, Upadhyaya
SA, Boop FA.
Treatment-related
calvarial lesions in pediatric brain tumor survivors.
Pediatr
Blood Cancer. 2020 Apr 14, 2020;67(6):e28189∟.
doi: 10.1002/pbc.28189∟.
PMID: 32286018∟.
Observational study. ˍ
Kaley
TJ, Panageas KS, Pentsova EI, Mellinghoff IK, Nolan C, Gavrilovic
I, DeAngelis LM, Abrey LE, Holland EC, Omuro A, Lacouture ME,
Ludwig E, Lassman AB.
Phase
I clinical trial of temsirolimus and perifosine for recurrent
glioblastoma.
Ann
Clin Transl Neurol.
2020
Apr 15, 2020;7(4):429-436∟.
doi: 10.1002/acn3.51009∟.
PMID: 32293798∟.
Interventional study. ˍ
Zhao
L, Zhang J, Liu Z, Zhao P.
Identification
of biomarkers for the transition from low-grade glioma to
secondary glioblastoma by an integrated bioinformatic analysis.
Am
J Transl Res. 2020 Apr 15, 2020;12(4):1222-1238∟.
PMID: 32355537∟.
Laboratory investigation. ˍ